DRKS00030743
Not yet recruiting
未知
Probing the efficacy of neurostimulation on reading and reading-related measures in adults with developmental dyslexia - ReDyslexia O4
Professur für Kognitive und Klinische Neurowissenschaften, Fakultät Psychologie, Technische Universität Dresden0 sites85 target enrollmentMarch 2, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Professur für Kognitive und Klinische Neurowissenschaften, Fakultät Psychologie, Technische Universität Dresden
- Enrollment
- 85
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •We plan to include 85 individuals (65 individuals diagnosed with DD and 20 controls) for this study.
- •The inclusion criteria for the participants with DD will be: (1\) right\-handed German speakers participants of both genders, diagnosed with DD according to participants’ self\-report, lifelong symptoms from childhood; (2\) reading accuracy and/or speed, as assessed by measures commonly used for diagnosis of DD in Germany (i.e., LGVT), of at least 1\.5 standard deviations (SD) below the mean for typically\-reading adults; (3\) non\-verbal Intelligence Quotient (nvIQ86\) higher or equal to 85 (IQ \= 85\); (4\) normal hearing and normal or corrected\-to\-normal vision.
- •For the control group, the inclusion criteria will be: (1\) right\-handed German speakers participants of both genders without any neurological disorders; (2\) non\-verbal Intelligence Quotient (nvIQ86\) higher or equal to 85 (IQ \= 85\); (3\) normal hearing and normal or corrected\-to\-normal vision.
Exclusion Criteria
- •The exclusion criteria for the participants with DD involve the following: (1\) the presence of other primary psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD, but not dyscalculia); (2\) a personal history of neurological/medical/genetic diseases; (3\) ongoing drug treatment influencing brain function; (4\) a personal history or first\-degree relatives’ history of epilepsy; (5\) incompatibility with tDCS; (6\) incompatibility with MRI.
- •The exclusion criteria for the healthy participants involve the following: (1\) the presence of any psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD); (2\) a personal history of neurological/medical/genetic diseases; (3\) ongoing drug treatment influencing brain function; (4\) a personal history or first\-degree relatives’ history of epilepsy; (5\) incompatibility with MRI.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
on-pharmacological techniques for cognitive improvement in schizophreniaSchizophreniaRBR-69g952niversidade Federal de São Paulo
Completed
Phase 2
The effectiveness of interactive neurostimulation in the management of acute postoperative pain following a total hip replacement – a pilot randomized controlled trialTotal hip replacementPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12609000776202Catherine Norman20
Recruiting
Not Applicable
The effect of tDCS brain stimulation on memory improvement in schizophrenic patientsIRCT20160528028118N2Tabriz University of Medical Sciences60
Completed
Not Applicable
Study of the Safety and Efficacy of Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Using a Vagal Nerve Stimulation Device in Patients with Active Refractory Crohn*s DiseaseCrohn's DiseaseInflammatory Bowel Disease10017969NL-OMON44525SetPoint Medical Corporation3
Completed
Not Applicable
Randomized controlled trial of neurostimulation treatment for apathy in schizophreniaapathylistlessnesspsychosis10039628NL-OMON41353niversitair Medisch Centrum Groningen150